A Follow-up Physician Survey to Evaluate Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe

Ophthalmology, Macular Degeneration Clinical Trial

Official title:

Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe: A Follow-up Physician Survey

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04067583
• Other study ID #: 20285
• Status: Completed
• Start date: October 8, 2019
• Est. completion date: April 23, 2020

Study information

• Verified date: April 2021
• Source: Bayer
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

With this follow up physician survey researcher want to collect the same data from all participants of the study using a highly structured questionnaire. The questionnaire will gather information related to physician characteristics and experience with Aflibercept, as well as assess physicians' knowledge and understanding of storage and preparation, proper injection technique, and the risks associated with Aflibercept injection into the eye (intravitreal injection). Analysis will be done using descriptive statistics.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 454
• Est. completion date: April 23, 2020
• Est. primary completion date: April 15, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Has signed informed consent

• Is a licensed and practicing ophthalmologist

• Has prescribed and/or administered aflibercept to at least one patient in the past 6 months

Exclusion Criteria:

• None

Related Conditions & MeSH terms

• Macular Degeneration
• Ophthalmology, Macular Degeneration

Intervention

Other:
• Physician questionnaire
This is a one-time cross-sectional survey of physicians, conducted electronically; there are no in person visits

Locations

Country	Name	City	State
Germany	Many locations	Multiple Locations

Sponsors (1)

Lead Sponsor	Collaborator
Bayer

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Percentage of physicians responding correctly to each individual knowledge question		Up to 1 year

External Links

•   Click here to find results for studies related to Bayer products